BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16979517)

  • 1. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
    Xu K; Nacheva E
    J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosecretory Primary Plasma Cell Leukemia with Atypical Morphological Abnormality.
    Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
    Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2014 Mar; ():. PubMed ID: 24659135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Cell Leukemia-Clinicopathological Profile from a Tertiary Care Center in Western India.
    Manimaran P; Rai V; Ranka R; Sawhney J
    South Asian J Cancer; 2023 Jul; 12(3):280-285. PubMed ID: 38047050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary plasma cell leukemia presented with atypical flower-like morphology.
    Jakovic L; Jovanovic J; Kurtovic NK; Fekete MD; Bogdanovic A
    Int J Lab Hematol; 2024 Jun; 46(3):425-426. PubMed ID: 38243765
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare case of a minimally secretory plasma cell leukemia with a hemorrhagic gastric plasmacytoma.
    Puri A; Lau MW; Zhao XF; Chan KC; Bader K
    Leuk Res Rep; 2018; 9():23-27. PubMed ID: 29892544
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Coccaro N; Tota G; Anelli L; Zagaria A; Casieri P; Cellamare A; Minervini CF; Minervini A; Cumbo C; Impera L; Brunetti C; Orsini P; Parciante E; Mestice A; Specchia G; Albano F
    Oncol Lett; 2016 Aug; 12(2):1460-1464. PubMed ID: 27446453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
    Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat plasma cell leukemia.
    van de Donk NW; Lokhorst HM; Anderson KC; Richardson PG
    Blood; 2012 Sep; 120(12):2376-89. PubMed ID: 22837533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH; Dominguez-Martinez VJ
    Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell leukemia. A report on 11 patients and review of the literature.
    Pasqualetti P; Festuccia V; Collacciani A; Acitelli P; Casale R
    Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell leukemia.
    Kosmo MA; Gale RP
    Semin Hematol; 1987 Jul; 24(3):202-8. PubMed ID: 3116673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
    Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
    O'Connell FP; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.